Prostate cancer is the second most common cancer in men, right behind skin cancer. That’s the bad news. The good news is if it’s caught early, it’s extremely treatable. But there’s more bad news — traditional treatment methods of screening and blinded biopsies can actually harm more men than they help. At Promaxo, they’re working to change all that by developing a lower-cost, portable MRI platform that enables high spatial resolution imaging in an office-based setting — without invasive procedures. Promaxo is helping make smart prostate cancer screening, diagnosis and treatment a reality today.